Validation of the FACIT‐Sp‐12 in a Dutch cohort of patients with advanced cancer

Abstract

Our analysis of the FACIT-Sp-12 revealed serious questions about three items and concerns about the Faith subscale. These problematic items deserve further attention so should be interpreted with care when using this scale. A future study could look into the items and test possible replacements.